- UGP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
-
6-K Filing
Ultrapar Participações (UGP) 6-KCurrent report (foreign)
Filed: 1 Apr 22, 5:08pm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K |
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 Or 15d-16 Of
The Securities Exchange Act Of 1934
For the month of April, 2022
Commission File Number: 001-14950
ULTRAPAR HOLDINGS INC.
(Translation of Registrant’s Name into English)
Brigadeiro Luis Antonio Avenue, 1343, 9th Floor
São Paulo, SP, Brazil 01317-910
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ____X____ Form 40-F ________
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ________ No ____X____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ________ No ____X____
ULTRAPAR PARTICIPAÇÕES S.A. |
MARKET ANNOUNCEMENT |
Ultrapar announces the closing of the sale of Oxiteno |
São Paulo, April 1, 2022 – Ultrapar Participações S.A. (B3: UGPA3 / NYSE: UGP, “Ultrapar" or “Company”) in addition to the Material Notice of August 16, 2021 and the Market Announcement of March 7, 2022, announces the conclusion of the sale of Oxiteno S.A. – Indústria e Comércio (“Oxiteno”) to Indorama Ventures PLC.
Pursuant to the Share Purchase Agreement, the initial payment of US$ 1,150,000,000.00, adjusted by the variations in working capital and net debt position of US$ 176,355,814.16, resulted in the total initial payment of US$ 1,326,355,814.16, which was settled today. This amount is still subject to final working capital and net debt adjustments. The final payment of US$ 150,000,000.00 will be settled in April 2024.
Consistent with the information that the Company has been providing to its shareholders and to the capital markets, the sale of Oxiteno is an important step of Ultrapar’s portfolio review process, seeking greater complementarity and synergies among its businesses.
Rodrigo de Almeida Pizzinatto
Chief Financial and Investor Relations Officer
Ultrapar Participações S.A.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: April 01, 2022
ULTRAPAR HOLDINGS INC. | |
By: /s/ Rodrigo de Almeida Pizzinatto | |
Name: Rodrigo de Almeida Pizzinatto | |
Title: Chief Financial and Investor Relations Officer |
(Market announcement)